Alector (ALEC) EBIT Margin (2018 - 2026)
Alector (ALEC) posted quarterly EBIT Margin of 2382.31% for Q1 2026, down 116579.0% year-over-year from N/an in Q1 2025, and down 275.54% quarter-over-quarter from 634.38% in Q4 2025.
Alector (ALEC) EBIT Margin (2018 - 2026) Analysis & Trends
Alector (ALEC) has reported EBIT Margin for 9 consecutive years, with 2382.31% the latest figure, recorded in Q1 2026.
- In Q1 2026, EBIT Margin fell 116579.0% year-over-year to 2382.31%; the TTM figure through Mar 2026 stood at 739.7% (down 57445.0% YoY), while the FY2025 annual figure was 741.3%, down 59711.0% from the prior year.
- EBIT Margin fell to 2382.31% in Q1 2026 per ALEC's latest filing, from 634.38% in the prior quarter.
- Across five years, EBIT Margin topped out at 11.87% in Q2 2022 and bottomed at 2382.31% in Q1 2026.
- Historically, EBIT Margin has averaged 516.33% across 5 years, with a median of 315.7% in 2024.
- Annual changes were most pronounced in 2022 — EBIT Margin jumped 110037 bps — and 2026, when it slumped 116579 bps.
- Alector's EBIT Margin stood at 383.92% in 2022, then advanced by 19 bps to 312.4% in 2023, then soared by 96 bps to 13.36% in 2024, then slumped by 4647 bps to 634.38% in 2025, then plunged by 276 bps to 2382.31% in 2026.
- Business Quant data shows ALEC's EBIT Margin at 2382.31% in Q1 2026, 634.38% in Q4 2025, and 1153.62% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 31.68% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.06% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -105.20% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.75% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 17.93% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.36% |
| 10 | Alector | 218.85 Mn | 46.05 Mn | - | -734.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -734.73% |
| Mar 31, 2026 | -2,382.31% |
| Dec 31, 2025 | -634.38% |
| Sep 30, 2025 | -1,153.62% |
| Jun 30, 2025 | -433.55% |
| Mar 31, 2025 | -1,216.52% |
| Dec 31, 2024 | -13.36% |
| Sep 30, 2024 | -315.70% |
| Jun 30, 2024 | -302.37% |
| Mar 31, 2024 | -275.01% |
| Dec 31, 2023 | -312.40% |
| Sep 30, 2023 | -555.31% |
| Jun 30, 2023 | -6.38% |
| Mar 31, 2023 | -302.83% |
| Dec 31, 2022 | -383.92% |
| Sep 30, 2022 | -321.49% |
| Jun 30, 2022 | 11.87% |
| Mar 31, 2022 | -180.29% |
| Dec 31, 2021 | -398.23% |
| Sep 30, 2021 | 69.25% |